Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence

PHASE3CompletedINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions
Opioid Use Disorders
Interventions
DRUG

CAM2038 SC injection

DRUG

SL BPN/NX tabs

DRUG

placebo SC injections

DRUG

SL placebo tablets

Trial Locations (36)

10019

STARS/Columbia University, New York

19104

The University of Pennsylvania Health System Treatment Research Center, Philadelphia

19428

Frost Medical Group, Conshohocken

29407

Carolina Clinical Trials, Inc, Charleston

32256

Dr Vijapura and Associates, Jacksonville

32751

TRY Research, Maitland

33161

Scientific Clinical Research, Inc., North Miami

33173

Tellus Clinical Research, Inc., Miami

33319

Innovative Clinical Research Inc, Lauderhill

35215

Parkway Medical Center, Birmingham

35565

Haleyville Clinical Research LLC, Haleyville

35570

Boyett Health Services Inc, Hamilton

39232

Precise Research Centers, Flowood

40508

University of Kentucky Medical Center, Lexington

44130

North Star Medical Research, Middleburg Heights

44718

Neuro-Behavioral Clinical Research Center, Canton

45417

Midwest Clinical Research Center, Dayton

63128

PsychCare Consultants Research, St Louis

63141

St. Louis Clinical Trials, St Louis

67203

Professional Research Network of Kansas, LLC, Wichita

73112

Rivus Wellness & Research Institute, Oklahoma City

75115

InSite Clinical Research, Dallas

84058

Aspen Clinical Research, Orem

90046

Synergist Research, West Hollywood

91402

Asclepes Research, Panorama City

91945

Synergy East, Lemon Grove

92056

North County Clinical Research, Oceanside

92103

Artemis Institute for Clinical Research, San Diego

94708

Care Practice, San Francisco

98107

Swedish Health Services, Seattle

02720

Stanley Street Treatment and Resources Inc, Fall River

02740

Novex Clinical Research, New Bedford

07823

Wellness and Research Center, Belvidere

08009

Comprehensive Clinical Research, Berlin

02865

Lincoln Research, Lincoln

05401

University of Vermont, Burlington

Sponsors
All Listed Sponsors
lead

Braeburn Pharmaceuticals

INDUSTRY

NCT02651584 - Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence | Biotech Hunter | Biotech Hunter